학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 50건 | 목록 1~10
Academic Journal
Proceedings of the National Academy of Sciences of the United States of America, 1987 Oct . 84(20), 7242-7245.
Academic Journal
Atkinson SJ; Oncology R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.; Bagal SK; Oncology R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.; Argyrou A; Discovery Sciences R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.; Askin S; Advanced Drug Delivery, Pharmaceutical Sciences, R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.; Cheung T; Oncology R&D, AstraZeneca, R&D Boston, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States.; Chiarparin E; Oncology R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.; Coen M; Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.; Collie IT; Discovery Sciences R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.; Dale IL; Discovery Sciences R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.; De Fusco C; Discovery Sciences R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.; Dillman K; Oncology R&D, AstraZeneca, R&D Boston, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States.; Evans L; Oncology R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.; Feron LJ; Oncology R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.; Foster AJ; Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.; Grondine M; Oncology R&D, AstraZeneca, R&D Boston, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States.; Kantae V; Discovery Sciences R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.; Lamont GM; Oncology R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.; Lamont S; Oncology R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.; Lynch JT; Oncology R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.; Nilsson Lill S; Data Sciences & Modelling, Pharmaceutical Sciences, R&D, AstraZeneca, Gothenburg 431 83, Sweden.; Robb GR; Oncology R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.; Saeh J; Oncology R&D, AstraZeneca, R&D Boston, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States.; Schimpl M; Discovery Sciences R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.; Scott JS; Oncology R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.; Smith J; Oncology R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.; Srinivasan B; Discovery Sciences R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.; Tentarelli S; Oncology R&D, AstraZeneca, R&D Boston, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States.; Vazquez-Chantada M; Discovery Sciences R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.; Wagner D; Oncology R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.; Walsh JJ; Discovery Sciences R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.; Watson D; Oncology R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.; Williamson B; Oncology R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.
Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4804 (Electronic) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: MEDLINE
Academic Journal
Mfuh AM; Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States.; Boerth JA; Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States.; Bommakanti G; Discovery Sciences, R&D, AstraZeneca, Waltham, Massachusetts 02451, United States.; Chan C; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K.; Chinn AJ; Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States.; Code E; Discovery Sciences, R&D, AstraZeneca, Waltham, Massachusetts 02451, United States.; Fricke PJ; Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States.; Giblin KA; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K.; Gohlke A; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K.; Hansel C; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K.; Hariparsad N; Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States.; Hughes SJ; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K.; Jin M; Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States.; Kantae V; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K.; Kavanagh SL; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K.; Lamb ML; Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States.; Lane J; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K.; Moore R; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K.; Puri T; Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States.; Quinn TR; Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States.; Reddy I; Discovery Sciences, R&D, AstraZeneca, Waltham, Massachusetts 02451, United States.; Robb GR; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K.; Robbins KJ; Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States.; Gancedo Rodrigo M; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K.; Isomorphic Laboratories, 280 Bishopsgate, London EC2M 4RB, U.K.; Schimpl M; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K.; Singh B; Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States.; Singh M; Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States.; Tang H; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K.; Thomson C; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K.; Walsh JJ; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K.; Ware J; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K.; Watson IDG; Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States.; Ye MW; Discovery Sciences, R&D, AstraZeneca, Waltham, Massachusetts 02451, United States.; Wrigley GL; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K.; Zhang AX; Discovery Sciences, R&D, AstraZeneca, Waltham, Massachusetts 02451, United States.; Zhang Y; Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States.; Grimster NP; Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States.
Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4804 (Electronic) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: MEDLINE
Academic Journal
Johannes JW; Chemistry, Oncology R&D, AstraZeneca, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States.; Balazs A; Chemistry, Oncology R&D, AstraZeneca, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States.; Barratt D; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 OWG, U.K.; Bista M; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 OWG, U.K.; Chuba MD; Chemistry, Oncology R&D, AstraZeneca, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States.; Cosulich S; Oncology Projects, Oncology R&D, AstraZeneca, Cambridge CB4 OWG, U.K.; Critchlow SE; Bioscience, Oncology R&D, AstraZeneca, Cambridge CB4 OWG, U.K.; Degorce SL; Chemistry, Oncology R&D, AstraZeneca, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States.; Di Fruscia P; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 OWG, U.K.; Edmondson SD; Chemistry, Oncology R&D, AstraZeneca, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States.; Embrey K; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 OWG, U.K.; Fawell S; Oncology Discovery, Oncology R&D, AstraZeneca, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States.; Ghosh A; Chemistry, Oncology R&D, AstraZeneca, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States.; Gill SJ; Oncology Safety, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge CB4 OWG, U.K.; Gunnarsson A; Discovery Sciences, R&D Gothenburg, AstraZeneca, KJ2, Pepparedsleden 1, SE-431 83 Mölndal, Sweden.; Hande SM; Chemistry, Oncology R&D, AstraZeneca, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States.; Heightman TD; Chemistry, Oncology R&D, AstraZeneca, Cambridge CB4 OWG, U.K.; Hemsley P; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 OWG, U.K.; Illuzzi G; Bioscience, Oncology R&D, AstraZeneca, Cambridge CB4 OWG, U.K.; Lane J; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 OWG, U.K.; Larner C; Oncology Safety, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge CB4 OWG, U.K.; Leo E; Bioscience, Oncology R&D, AstraZeneca, Cambridge CB4 OWG, U.K.; Liu L; Pharmaron Beijing Co., Ltd., 6 Taihe Road, BDA, Beijing 100176, P. R. China.; Madin A; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 OWG, U.K.; Martin S; DMPK, Oncology R&D, AstraZeneca, Cambridge CB4 OWG, U.K.; McWilliams L; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 OWG, U.K.; O'Connor MJ; Bioscience, Oncology R&D, AstraZeneca, Cambridge CB4 OWG, U.K.; Orme JP; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 OWG, U.K.; Pachl F; Discovery Sciences, R&D, AstraZeneca, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States.; Packer MJ; Computational Chemistry, Oncology R&D, AstraZeneca, Cambridge CB4 OWG, U.K.; Pei X; Pharmaron Beijing Co., Ltd., 6 Taihe Road, BDA, Beijing 100176, P. R. China.; Pike A; DMPK, Oncology R&D, AstraZeneca, Cambridge CB4 OWG, U.K.; Schimpl M; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 OWG, U.K.; She H; Pharmaron Beijing Co., Ltd., 6 Taihe Road, BDA, Beijing 100176, P. R. China.; Staniszewska AD; Bioscience, Oncology R&D, AstraZeneca, Cambridge CB4 OWG, U.K.; Talbot V; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 OWG, U.K.; Underwood E; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 OWG, U.K.; Varnes JG; Chemistry, Oncology R&D, AstraZeneca, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States.; Xue L; Pharmaron Beijing Co., Ltd., 6 Taihe Road, BDA, Beijing 100176, P. R. China.; Yao T; Pharmaron Beijing Co., Ltd., 6 Taihe Road, BDA, Beijing 100176, P. R. China.; Zhang K; Pharmaron Beijing Co., Ltd., 6 Taihe Road, BDA, Beijing 100176, P. R. China.; Zhang AX; Discovery Sciences, R&D, AstraZeneca, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States.; Zheng X; Chemistry, Oncology R&D, AstraZeneca, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States.
Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4804 (Electronic) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: MEDLINE
Academic Journal
Erb KJ; Institute of Virology and Immunobiology, University of Würzburg, Germany.; Hanke TSchimpl AHünig TStingl GElbe A
Publisher: Wiley-VCH Country of Publication: Germany NLM ID: 1273201 Publication Model: Print Cited Medium: Print ISSN: 0014-2980 (Print) Linking ISSN: 00142980 NLM ISO Abbreviation: Eur J Immunol Subsets: MEDLINE
Academic Journal
Paraskevopoulou V; School of Pharmacy, University of Nottingham, Nottingham, NG7 2RD, United Kingdom.; Schimpl M; Structure, Biophysics and Fragment-based Lead Generation, Discovery Sciences, R&D, AstraZeneca, Cambridge, United Kingdom.; Overman RC; Protein Science, Discovery Sciences, R&D, AstraZeneca, Alderley Park, United Kingdom.; Stolnik S; School of Pharmacy, University of Nottingham, Nottingham, NG7 2RD, United Kingdom.; Chen Y; Alberta Glycomics Centre and Department of Chemistry, University of Alberta, Edmonton, T6G 2G2, Canada.; Nguyen L; Alberta Glycomics Centre and Department of Chemistry, University of Alberta, Edmonton, T6G 2G2, Canada.; Winkler GS; School of Pharmacy, University of Nottingham, Nottingham, NG7 2RD, United Kingdom.; Gellert P; Innovation Strategy & External Liaison, Pharmaceutical Technology & Development, Operations, AstraZeneca, Macclesfield, United Kingdom.; Klassen JS; Alberta Glycomics Centre and Department of Chemistry, University of Alberta, Edmonton, T6G 2G2, Canada.; Falcone FH; School of Pharmacy, University of Nottingham, Nottingham, NG7 2RD, United Kingdom.; Institute for Parasitology, Justus-Liebig-University Gießen, Schubertstr. 81, D-35392, Gießen, Germany.
Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101767537 Publication Model: eCollection Cited Medium: Internet ISSN: 2665-928X (Electronic) Linking ISSN: 2665928X NLM ISO Abbreviation: Curr Res Struct Biol Subsets: PubMed not MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Schimpl, V
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어